Skip to main content
×
×
Home

The impact of maternal synthetic glucocorticoid administration in late pregnancy on fetal and early neonatal hypothalamic–pituitary–adrenal axes regulatory genes is dependent upon dose and gestational age at exposure

  • S. Li (a1) (a2), T. J. M. Moss (a1) (a3), I. Nitsos (a1) (a3), S. G. Matthews (a4), J. R. G. Challis (a1) (a4), J. P. Newnham (a1) (a2) and D. M. Sloboda (a5)...
Abstract

In this study, we determined the gene and/or protein expression of hypothalamic–pituitary–adrenal (HPA) axis regulatory molecules following synthetic glucocorticoid exposures. Pregnant sheep received intramuscular saline or betamethasone (BET) injections at 104 (BET-1), 104 and 111(BET-2) or 104, 111 and 118 (BET-3) days of gestation (dG). Samples were collected at numerous time-points between 75 dG and 12 weeks postnatal age. In the BET-3 treatment group, fetal plasma cortisol levels were lower at 145 dG than controls and gestational length was lengthened significantly. The cortisol:adrenocorticotropic hormone (ACTH) ratio in fetal plasma of control and BET-3 fetuses rose significantly between132 and 145 dG, and remained elevated in lambs at 6 and 12 weeks of age; this rise was truncated at day 145 in fetuses of BET-3 treated mothers. After BET treatment, fetal and postnatal pituitary proopiomelanocortin mRNA levels were reduced from 109 dG to 12 weeks postnatal age; pituitary prohormone convertase 1 and 2 mRNA levels were reduced at 145 dG and postnatally; hypothalamic arginine vasopressin mRNA levels were lowered at all time-points, but corticotrophin-releasing hormone mRNA levels were reduced only in postnatal lambs. Maternal BET increased late fetal and/or postnatal adrenal mRNA levels of ACTH receptor and 3β hydroxysteroid dehydrogenase but decreased steroidogenic acute regulatory protein and P450 17-α hydroxylase. The altered mRNA levels of key HPA axis regulatory proteins after maternal BET injections suggests processes that may subserve long-term changes in HPA activity in later life after prenatal exposure to synthetic glucocorticoids.

Copyright
Corresponding author
Address for correspondence: S. Li, School of Women's and Infants’ Health, The University of Western Australia, M550, Crawley, WA 6009, Australia. Email Shaofu.li@uwa.edu.au
References
Hide All
1.Polyakov, A, Cohen, S, Marita, B, et al. Patterns of antenatal corticosteroid prescribing 1998–2004. Aust N Z J Obstet Gynaecol. 2007; 47, 4245.
2.Crowley, P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev. 2000, CD000065.
3.Ikegami, M, Jobe, AH, Newnham, J, et al. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med. 1997; 156, 178184.
4.Moss, TJ, Sloboda, DM, Gurrin, LC, et al. Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol Regul Integr Comp Physiol. 2001; 281, R960R970.
5.Sloboda, DM, Newnham, JP, Challis, JR. Effects of repeated maternal betamethasone administration on growth and hypothalamic-pituitary-adrenal function of the ovine fetus at term. J Endocrinol. 2000; 165, 7991.
6.Sloboda, DM, Newnham, JP. Repeated maternal glucocorticoid administration and the developing liver in fetal sheep. J Endocrinol. 2002; 175, 535543.
7.Sloboda, DM, Challis, JR, Moss, TJ, Newnham, JP. Synthetic glucocorticoids: antenatal administration and long-term implications. Curr Pharm Des. 2005; 11, 14591472.
8.Newnham, JP. Is prenatal glucocorticoid administration another origin of adult disease? Clin Exp Pharmacol Physiol. 2001; 28, 957961.
9.Sloboda, DM, Moss, TJ, Gurrin, LC, Newnham, JP, Challis, JR. The effect of prenatal betamethasone administration on postnatal ovine hypothalamic-pituitary-adrenal function. J Endocrinol. 2002; 172, 7181.
10.Sloboda, DM, Moss, TJ, Li, S, et al. Prenatal betamethasone exposure results in pituitary-adrenal hyporesponsiveness in adult sheep. Am J Physiol Endocrinol Metab. 2007; 292, E61E70.
11.Benediktsson, R, Lindsay, RS, Noble, J, Seckl, JR, Edwards, CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet. 1993; 341, 339341.
12.Cleasby, ME, Livingstone, DE, Nyirenda, MJ, Seckl, JR, Walker, BR. Is programming of glucocorticoid receptor expression by prenatal dexamethasone in the rat secondary to metabolic derangement in adulthood? Eur J Endocrinol. 2003; 148, 129138.
13.Owen, D, Matthews, SG. Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function in juvenile guinea pigs. J Neuroendocrinol. 2007; 19, 172180.
14.Banjanin, S, Kapoor, A, Matthews, SG. Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function and blood pressure in mature male guinea pigs. J Physiol. 2004; 558, 305318.
15.Fowden, AL, Li, J, Forhead, AJ. Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance? Proc Nutr Soc. 1998; 57, 113122.
16.McDonald, TJ. Hypothalamic glucocorticoid implants prevent fetal ovine adrenocorticotropin secretion in response to stress. Endocrinology. 1990; 127, 28622868.
17.Akagi, K, Berdusco, ET, Challis, JR. Cortisol inhibits ACTH but not the AVP response to hypoxaemia in fetal lambs at days 123-128 of gestation. J Dev Physiol. 1990; 14, 319324.
18.Moss, TJ, Harding, R, Newnham, JP. Lung function, arterial pressure and growth in sheep during early postnatal life following single and repeated prenatal corticosteroid treatments. Early Hum Dev. 2002; 66, 1124.
19.Jobe, AH, Moss, TJ, Nitsos, I, et al. Betamethasone for lung maturation: testing dose and formulation in fetal sheep. Am J Obstet Gynecol. 2007; 197:523 e521526.
20.Gatford, KL, Owens, JA, Li, S, et al. Repeated betamethasone treatment of pregnant sheep programs persistent reductions in circulating IGF-I and IGF-binding proteins in progeny. Am J Physiol Endocrinol Metab. 2008; 295, E170E178.
21.Sloboda, DM, Moss, TJ, Li, S, et al. Hepatic glucose regulation and metabolism in adult sheep: effects of prenatal betamethasone. Am J Physiol Endocrinol Metab. 2005; 289, E721E728.
22.Sloboda, DM, Moss, TJ, Li, S, et al. Expression of glucocorticoid receptor, mineralocorticoid receptor, and 11beta-hydroxysteroid dehydrogenase 1 and 2 in the fetal and postnatal ovine hippocampus: ontogeny and effects of prenatal glucocorticoid exposure. J Endocrinol. 2008; 197, 213220.
23.Gutierrez-Adan, A, Cushwa, WT, Anderson, GB, Medrano, JF. Ovine-specific Y-chromosome RAPD-SCAR marker for embryo sexing. Anim Genet. 1997; 28, 135138.
24.Holloway, AC, Howe, DC, Chan, G, et al. Urocortin: a mechanism for the sustained activation of the HPA axis in the late-gestation ovine fetus? Am J Physiol Endocrinol Metab. 2002; 283, E165E171.
25.Zarkawi, M, Soukouti, A. Serum progesterone levels using radioimmunoassay during oestrous cycle of indigenous Damascus does. NZ J Agric Res. 2001; 44, 165170.
26.Bloomfield, FH, Oliver, MH, Hawkins, P, et al. Periconceptional undernutrition in sheep accelerates maturation of the fetal hypothalamic-pituitary-adrenal axis in late gestation. Endocrinology. 2004; 145, 42784285.
27.McCabe, L, Marash, D, Li, A, Matthews, SG. Repeated antenatal glucocorticoid treatment decreases hypothalamic corticotropin releasing hormone mRNA but not corticosteroid Receptor mRNA expression in the fetal guinea-pig Brain. J Neuroendocrinol. 2001; 13, 425431.
28.Zhao, HF, Simard, J, Labrie, C, Breton, N, Rheaume, E. Molecular cloning, cDNA structure and predicted amino acid sequence of bovine 3 beta-hydroxy-5-ene steroid dehydrogenase/delta 5-delta 4 isomerase. FEBS Lett. 1989; 259, 153157.
29.Dodic, M, Hantzis, V, Duncan, J, et al. Programming effects of short prenatal exposure to cortisol. In FASEB. 2002; 16, 10171026.
30.Van Harmelen, V, Ariapart, P, Hoffstedt, J, et al. Increased adipose angiotensinogen gene expression in human obesity. In NAASO. 2000; 8, 337341.
31.Jobe, AH, Wada, N, Berry, LM, Ikegami, M, Ervin, MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol. 1998; 178, 880885.
32.Moss, TJM, Doherty, DA, Nitsos, I, et al. Effects into adulthood of single or repeated antenatal corticosteroids in sheep. Am J Obstet Gynecol. 2005; 192, 146152.
33.Matthews, SG, Challis, JR. CRH and AVP-induced changes in synthesis and release of ACTH from the ovine fetal pituitary in vitro: negative influences of cortisol. Endocrine. 1997; 6, 293300.
34.Challis, JRG, Matthews, SG, Gibb, W, Lye, SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000; 21, 514550.
35.Levidiotis, ML, Wintour, EM, McKinley, MJ, Oldfield, BJ. Hypothalamic-hypophyseal vascular connections in the fetal sheep. Neuroendocrinology. 1989; 49, 4750.
36.Berdusco, ET, Hammond, GL, Jacobs, RA, et al. Glucocorticoid-induced increase in plasma corticosteroid-binding globulin levels in fetal sheep is associated with increased biosynthesis and alterations in glycosylation. Endocrinology. 1993; 132, 20012008.
37.Berdusco, ET, Milne, WK, Challis, JR. Low-dose cortisol infusion increases plasma corticosteroid-binding globulin (CBG) and the amount of hepatic CBG mRNA in fetal sheep on day 100 of gestation. J Endocrinol. 1994; 140, 425430.
38.Clifton, VL. Sexually dimorphic effects of maternal asthma during pregnancy on placental glucocorticoid metabolism and fetal growth. Cell Tissue Res. 2005; 322, 6371.
39.Braun, T, Li, S, Sloboda, DM, et al. Effects of maternal dexamethasone treatment in early pregnancy on pituitary-adrenal axis in fetal sheep. Endocrinology. 2009; 150, 54665477.
40.Ross, JT, McMillen, IC, Adams, MB, Coulter, CL. A premature increase in circulating cortisol suppresses expression of 11beta hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid in the adrenal of the fetal sheep. Biol Reprod. 2000; 62, 12971302.
41.MacLaughlin, SM, Walker, SK, Kleemann, DO, et al. Impact of periconceptional undernutrition on adrenal growth and adrenal insulin-like growth factor and steroidogenic enzyme expression in the sheep fetus during early pregnancy. Endocrinology. 2007; 148, 19111920.
42.Matthews, SG, Han, X, Lu, F, Challis, JR. Developmental changes in the distribution of pro-opiomelanocortin and prolactin mRNA in the pituitary of the ovine fetus and lamb. J Mol Endocrinol. 1994; 13, 175185.
43.Matthews, SG, Owen, D, Banjanin, S, Andrews, MH. Glucocorticoids, hypothalamo-pituitary-adrenal (HPA) development, and life after birth. Endocr Res. 2002; 28, 709718.
44.Matthews, SG, Challis, JR. Regulation of the hypothalamo-pituitary-adrenocortical axis in fetal sheep. Trends Endocrinol Metab. 1996; 7, 239246.
45.Seckl, JR, Cleasby, M, Nyirenda, MJ. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney Int. 2000; 57, 14121417.
46.Braun, T, Li, S, Moss, TJ, et al. Maternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep. J Endocrinol. 2007; 194, 337347.
47.Newnham, JP, Moss, TJM, Nitsos, I, Sloboda, DM. Antenatal corticosteroids: the good, the bad and the unknown. Curr Opin Obstet Gynecol. 2002; 14, 607612.
48.Matthews, SG, Challis, JR. Regulation of CRH and AVP mRNA in the developing ovine hypothalamus: effects of stress and glucocorticoids. Am J Physiol. 1995; 268, E1096E1107.
49.Bloomfield, FH, Oliver, MH, Hawkins, P, et al. A periconceptional nutritional origin for noninfectious preterm birth. Science. 2003; 300, 606.
50.Matthews, SG, Yang, K, Challis, JR. Changes in glucocorticoid receptor mRNA in the developing ovine pituitary and the effects of exogenous cortisol. J Endocrinol. 1995; 144, 483490.
51.Jones, CT, Roebuck, MM. ACTH peptides and the development of the fetal adrenal. J Steroid Biochem. 1980; 12, 7782.
52.Rousseau, K, Kauser, S, Pritchard, LE, et al. Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J. 2007; 21, 18441856.
53.Rainey, WE, Carr, BR, Wang, ZN, Parker, CR Jr. Gene profiling of human fetal and adult adrenals. J Endocrinol. 2001; 171, 209215.
54.Mansfield, CW, Carr, BR, Faye-Petersen, OM, et al. Differential gene expression in the adrenals of normal and anencephalic fetuses and studies focused on the Fras-1-related extracellular matrix protein (FREM2) gene. Reprod Sci. 2011; 18, 11461153.
55.Moritz, K, Butkus, A, Hantzis, V, et al. Prolonged low-dose dexamethasone, in early gestation, has no long-term deleterious effect on normal ovine fetuses. Endocrinology. 2002; 143, 11591165.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of Developmental Origins of Health and Disease
  • ISSN: 2040-1744
  • EISSN: 2040-1752
  • URL: /core/journals/journal-of-developmental-origins-of-health-and-disease
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 2
Total number of PDF views: 29 *
Loading metrics...

Abstract views

Total abstract views: 220 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 12th June 2018. This data will be updated every 24 hours.